Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.84 +0.02 (+2.51%)
At close: Sep 11, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Prepaid Assets (2020 - 2026)

Rani Therapeutics Holdings (RANI) posted Prepaid Assets of $1.1 million for Q2 2026, down 33.78% on a QoQ basis from $1.6 million in Q1 2026, and up 27.19% year-over-year from $857000.0 in Q2 2025.

Analysis

Rani Therapeutics Holdings (RANI) Prepaid Assets (2020 - 2026) Analysis & Trends

Rani Therapeutics Holdings has reported Prepaid Assets for 7 years, with the latest figure at $1.1 million in Q2 2026.

  • On a quarterly basis, Prepaid Assets rose 27.19% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $1.1 million, a 27.19% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, down 6.38% from the prior year.
  • Prepaid Assets was $1.1 million for Q2 2026 at Rani Therapeutics Holdings, down from $1.6 million in the prior quarter.
  • The five-year high for Prepaid Assets was $2.7 million in Q3 2023, with the low at $811000.0 in Q3 2025.
  • Average Prepaid Assets over 5 years is $1.6 million, with a median of $1.7 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: Prepaid Assets jumped 392.12% in 2022, then sank 58.77% in 2025.
  • Over 5 years, Prepaid Assets stood at $2.4 million in 2022, then slipped by 5.49% to $2.3 million in 2023, then slipped by 27.34% to $1.7 million in 2024, then decreased by 6.38% to $1.6 million in 2025, then sank by 30.57% to $1.1 million in 2026.
  • The last three Prepaid Assets figures came in at $1.1 million (Q2 2026), $1.6 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Rani Therapeutics Holdings 157.97 Mn 157.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.09 Mn
Mar 31, 2026 1.65 Mn
Dec 31, 2025 1.57 Mn
Sep 30, 2025 811,000.00
Jun 30, 2025 857,000.00
Mar 31, 2025 1.33 Mn
Dec 31, 2024 1.68 Mn
Sep 30, 2024 1.97 Mn
Jun 30, 2024 1.13 Mn
Mar 31, 2024 1.81 Mn
Dec 31, 2023 2.31 Mn
Sep 30, 2023 2.70 Mn
Jun 30, 2023 1.77 Mn
Mar 31, 2023 1.75 Mn
Dec 31, 2022 2.44 Mn
Sep 30, 2022 2.55 Mn
Jun 30, 2022 812,000.00
Mar 31, 2022 1.42 Mn
Dec 31, 2021 2.14 Mn
Sep 30, 2021 2.62 Mn